Saddi Turner, NP
Family · Jonesville, MINPI 1255837878
Payments from drug & device makers
Across 277 payments — averaging $15.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$726
- AbbVie$392
- AstraZeneca$385
- Otsuka America Pharmaceutical, Inc.$320
- Merck$255
- Pfizer$253
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,370100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 49 | $726 |
| AbbVie | 26 | $392 |
| AstraZeneca | 18 | $385 |
| Otsuka America Pharmaceutical, Inc. | 24 | $320 |
| Merck | 13 | $255 |
| Pfizer | 14 | $253 |
| Johnson & Johnson | 17 | $245 |
| Lilly USA, LLC | 17 | $234 |
| Bayer | 12 | $218 |
| Amgen | 11 | $157 |
| GSK | 10 | $141 |
| Corcept Therapeutics | 8 | $123 |
| Nestle Healthcare Nutrition Inc. | 6 | $97 |
| Boehringer Ingelheim | 5 | $72 |
| Dexcom, Inc. | 4 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| Biohaven Pharmaceuticals, Inc. | 4 | $60 |
| Novartis | 4 | $59 |
| Actelion Pharmaceuticals US, Inc. | 3 | $58 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $58 |
| Amarin Pharma, Inc. | 4 | $57 |
| Kowa Pharmaceuticals America, Inc. | 4 | $51 |
| Sanofi-aventis U.S. LLC | 3 | $42 |
| Eisai Inc. | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $33 |
| Genentech USA, Inc. | 2 | $29 |
| Cognoa, Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Lundbeck LLC | 1 | $15 |
| Mylan Specialty L.p. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
| Jazz Pharmaceuticals Inc. | 1 | $12 |
How this compares
$4,370 in reported general payments places this provider in the 90th percentile of 3,657 family providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 37 | $28,929 |
| EliquisApixaban | 31 | $28,397 |
| JardianceEmpagliflozin | 13 | $21,196 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $4,795 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 11 | $3,265 |
| Levothyroxine Sodium | 198 | $2,673 |
| Atorvastatin Calcium | 150 | $2,057 |
| Losartan Potassium | 125 | $1,902 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 35 | $1,571 |
| Omeprazole | 92 | $1,529 |
| Duloxetine Hcl | 45 | $1,180 |
| Metoprolol Succinate | 50 | $1,149 |
| Lisinopril | 142 | $1,139 |
| Bupropion XlBupropion Hcl | 28 | $1,026 |
| Pantoprazole Sodium | 25 | $914 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $141 | $28,92937 claims |
| PfizerEliquis | $253 | $28,39731 claims |
| Boehringer IngelheimJardiance | $72 | $21,19613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,657 family providers in Michigan.
Other family in Jonesville
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
- Tracy RobertsonBay City$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.